Free tool
Rare disease stocks
We cover 43 companies grouped under the Rare disease theme. The median market value in the group is $23.74M. Across the group, the median move over the past trading day is −0.69%. 26% of the 42 with a 200-day average trade above it. Price change over the past year runs from −93.8% to +126.6% across the middle 80 percent of the group, with a median of −49.8%.
Other lists in this group
SaaSAI applicationsCybersecuritySemiconductor designSemiconductor equipmentFintech softwarePayment processingEcommerce marketplacesStreaming mediaGaming softwareOncologyRare diseaseMedical devicesCell therapyDiagnosticsRegional banksAsset managementGold miningCryptocurrency and digital assetsSpecialty chemicalsAll stocks
Table
43 of 268 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return |
|---|---|---|---|---|
| FBIO | Fortress Biotech, Inc. | $94.38M | Micro cap | +20.09% |
| PLYX | Polaryx Therapeutics, Inc. | $94.21M | Micro cap | −94.03% |
| RLYB | Rallybio Corporation | $89.64M | Micro cap | +257.63% |
| GOSS | Gossamer Bio, Inc. | $85.01M | Micro cap | −92.93% |
| TELO | Telomir Pharmaceuticals, Inc. | $80.47M | Micro cap | −20.95% |
| TENX | Tenax Therapeutics, Inc. | $79.34M | Micro cap | −64.19% |
| FBIOP | Fortress Biotech, Inc. | $71.45M | Micro cap | +131.74% |
| SPRO | Spero Therapeutics, Inc. | $71.05M | Micro cap | −38.38% |
| RNTX | Rein Therapeutics Inc. | $69.01M | Micro cap | −27.27% |
| IMA | ImageneBio, Inc. | $61.64M | Micro cap | −60.19% |
| SCYX | SCYNEXIS, Inc. | $56.41M | Micro cap | +579.04% |
| ATYR | aTyr Pharma, Inc. | $54.05M | Micro cap | −89.34% |
| NSRX | Nasus Pharma Ltd. | $48.01M | Micro cap | −49.75% |
| MCRB | Seres Therapeutics, Inc. | $47.81M | Micro cap | −74.79% |
| EDSA | Edesa Biotech, Inc. | $47.63M | Micro cap | +105.83% |
| GRCE | Grace Therapeutics, Inc. | $46.28M | Micro cap | −29.97% |
| MREO | Mereo BioPharma Group plc | $44.39M | Micro cap | −84.20% |
| NNVC | NanoViricides, Inc. | $32.68M | Micro cap | −9.86% |
| QNCX | Quince Therapeutics, Inc. | $31.84M | Micro cap | +100.71% |
| BRNS | Barinthus Biotherapeutics plc | $28.86M | Micro cap | −38.04% |
| JSPR | Jasper Therapeutics, Inc. | $23.96M | Micro cap | −75.24% |
| TVRD | Tvardi Therapeutics, Inc. | $23.74M | Micro cap | −94.18% |
| COCP | Cocrystal Pharma, Inc. | $21.57M | Micro cap | −27.74% |
| VYNE | VYNE Therapeutics Inc | $19.07M | Micro cap | +8660.74% |
| KTTA | Pasithea Therapeutics Corp. | $19.05M | Micro cap | −24.30% |
| CALC | CalciMedica, Inc. | $18.06M | Micro cap | −79.74% |
| CMMB | Chemomab Therapeutics Ltd. | $16.85M | Micro cap | −25.57% |
| HIND | Vyome Holdings, Inc. | $15.16M | Micro cap | −79.68% |
| AZTR | Azitra, Inc. | $10.48M | Micro cap | −83.21% |
| QNRX | Quoin Pharmaceuticals, Ltd. | $10.40M | Micro cap | −29.81% |
| IMRN | Immuron Limited | $9.20M | Micro cap | −35.77% |
| SNGX | Soligenix, Inc. | $8.36M | Micro cap | −87.20% |
| XCUR | Exicure, Inc. | $8.25M | Micro cap | −77.93% |
| INM | InMed Pharmaceuticals Inc. | $7.64M | Micro cap | −36.44% |
| PULM | Pulmatrix, Inc. | $5.57M | Micro cap | −68.62% |
| CVKD | Cadrenal Therapeutics, Inc. | $4.80M | Micro cap | −88.87% |
| JAGX | Jaguar Health, Inc. | $4.78M | Micro cap | −98.52% |
| GLMD | Galmed Pharmaceuticals Ltd. | $4.48M | Micro cap | +211.51% |
| GRI | GRI Bio, Inc. | $4.28M | Micro cap | −95.23% |
| XRTX | XORTX Therapeutics Inc. | $4.03M | Micro cap | −43.99% |
| SXTP | 60 Degrees Pharmaceuticals, Inc. | $3.80M | Micro cap | −78.23% |
| MTNB | Matinas BioPharma Holdings, Inc. | $2.89M | Micro cap | −90.08% |
| VBIO | Valion Bio, Inc. | $647.60K | Micro cap | −94.92% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.